Citadel Advisors’s UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN MLPL Stock Holding History
Bought
Maintained
Sold
Other funds holding MLPL
EGA
SCA
BCFA
PCM
CFA
PSI
WRM
Citadel Advisors's MLPL Position: Q4 2015 in Review
Citadel Advisors sold out of UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN (MLPL) in Q4 2015, closing a stake of 9,470 shares — an estimated $232K sold.
Citadel Advisors first reported a position in MLPL in Q3 2015 and held it in 1 quarter. The position peaked at $232K in Q3 2015. 18 funds tracked by Wall St. Rank hold MLPL as of Q4 2015.
- Citadel Advisors reported no remaining UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position as of Q4 2015 after selling out during the quarter.
- Citadel Advisors sold 9,470 UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN shares in Q4 2015, an estimated $232K.
- Citadel Advisors first reported a position in UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN in Q3 2015 and held it in 1 quarter.
- Citadel Advisors's UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position peaked at $232K in Q3 2015.
- 18 funds tracked by Wall St. Rank held UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN as of Q4 2015.
Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.